AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed an amended Schedule 13G with the SEC on November 13, 2026, reporting beneficial ownership of 2,096,939 shares of Vanda Pharmaceuticals Inc. common stock as of September 30, 2026.
Key Highlights
- Aggregate beneficial ownership: AQR Capital Management, LLC and AQR Capital Management Holdings, LLC each report beneficial ownership of 2,096,939 shares of Vanda Pharmaceuticals Inc. common stock.
- Percent of class: The 2,096,939 shares represent 3.47% of the class, according to the filing.
- Shared voting power: Both reporting persons report shared voting power over 1,971,025 shares, with sole voting power of 0.
- Shared dispositive power: Both entities report shared dispositive power over 2,096,939 shares, with sole dispositive power of 0.
- Event date: The date of the event requiring this filing is stated as September 30, 2026.
- Corporate relationship: According to the filing, AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
AQR Capital Management Reports Amended Ownership Position in Vanda Pharmaceuticals
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed Amendment No. 1 to a Schedule 13G with the Securities and Exchange Commission on November 13, 2026, covering common stock of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), par value $0.001 per share, CUSIP 921659108. The filing was triggered by an event dated September 30, 2026, and was signed by Henry Parkin as Authorized Signatory on behalf of both entities.
According to the filing, the aggregate amount beneficially owned by each reporting person is 2,096,939 shares, equaling 3.47% of the class. Neither entity holds sole voting power or sole dispositive power over any shares. Shared voting power covers 1,971,025 shares for both AQR Capital Management, LLC and AQR Capital Management Holdings, LLC, while shared dispositive power extends to the full 2,096,939 shares reported for each entity.
The filing identifies AQR Capital Management, LLC as an investment adviser (type "IA") and AQR Capital Management Holdings, LLC as a holding company (type "HC"), both organized in the United States and headquartered at One Greenwich Plaza, Suite 130, Greenwich, Connecticut 06830. The filing certifies, in the words of the document, that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." Item 5 of the filing designates this as ownership of 5 percent or less of the class.
What Was Disclosed
AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC disclosed an amended Schedule 13G position of 2,096,939 shares, or 3.47%, of Vanda Pharmaceuticals Inc. common stock, with shared but no sole voting or dispositive power, as of September 30, 2026.




Please wait processing your request...